Who is sponsoring NCT05960370?

NCT05960370 is sponsored by Instituto Bernabeu.

What drugs are being tested in NCT05960370?

Interventions in NCT05960370: Observational non intervention study.

What condition does NCT05960370 study?

NCT05960370 studies Infertility Due to Nonimplantation.

Is NCT05960370 still recruiting?

NCT05960370 is currently recruiting now. Last updated 3 October 2024.

Last reviewed 2024-10-03 · How we verify

NCT05960370: Compaction

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle

Recruiting now Last updated 3 October 2024

What this trial tests

trial testing Observational non intervention study in Infertility Due to Nonimplantation in 206 participants. Currently enrolling.

Timeline

15 June 2022

Primary endpoint
15 June 2025

15 June 2025

Quick facts

Lead sponsor	Instituto Bernabeu
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	206
Start date	15 June 2022
Primary completion	15 June 2025
Estimated completion	15 June 2025
Sites	1 location across Spain

Drugs / interventions tested

Observational non intervention study

Conditions studied

Infertility Due to Nonimplantation — all drugs for Infertility Due to Nonimplantation →

Sponsor

Instituto Bernabeu — full company profile →

Who can join

Adults 18 to 50, female only, with Infertility Due to Nonimplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicenter prospective observational cohort study, comparing ongoing pregnancy rates in natural cycles for euploid embryo transfer in patients who present endometrial compaction at the time of the transfer versus those who have a stable or greater endometrial thickness with respect to the estrogenic phase.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Instituto Bernabeu trials

Trials by the same sponsor.

NCT07364526 — Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients · recruiting
NCT07270081 — Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEID · NA · completed
NCT06195163 — TRAP Study: Testosterone for Androgen Receptor Polymorphism · Phase 4 · not yet recruiting
NCT05954962 — Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. · Phase 4 · completed
NCT05815719 — Continuous Double Ovarian Stimulation. · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05960370 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Bernabeu
Last refreshed: 3 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05960370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing